Human retinal organoids for modelling dry age-related macular degeneration and screening drugs [PDF]
Genes and DiseasesAge-related macular degeneration (AMD) poses a significant threat to the vision of the elderly population globally. Unfortunately, there is no effective treatment available for dry AMD.
Xiaolu Hao +4 more
doaj +2 more sources
Dry age-related macular degeneration - therapeutic possibilities and research directions [PDF]
Farmacja Polska, 2022 Age-related macular degeneration (AMD) is a major cause of vision loss in developed countries, especially in the elderly population. AMD is a multifactorial disease which etiology is not completely understood.
Alicja Zajdel
doaj +1 more source
Response to “Letter to the Editor Regarding ‘Multiwavelength Photobiomodulation Improves Multiple Aspects of Visual Function in Early-Stage Dry Age-Related Macular Degeneration’” [PDF]
Ophthalmology and TherapyCem Küçükerdönmez +1 more
doaj +2 more sources
Treatment Methods Dry Form of Age Macular Degeneration — History and Prospects. Review
Oftalʹmologiâ, 2023 Age related macular degeneration is a leading cause of vision loss and an increasing problem of disability throughout the world among adults. That revue covers historical points, risk factors, pathogenesis, classification and current treatment ways of ...
A. N. Kulikov +2 more
doaj +1 more source
Treatment of Dry Age-Related Macular Degeneration [PDF]
Ophthalmic Research, 2014 A number of different approaches are under development for treating nonexudative manifestations of age-related macular degeneration (AMD). Some interventions target specific pathways that are believed to play a role in AMD pathogenesis, e.g. oxidative damage, lipofuscin accumulation, chronic inflammation (including complement activation), extracellular
Querques G +7 more
openaire +4 more sources
Recent Advances in Age-Related Macular Degeneration Therapies
Molecules, 2022 Age-related macular degeneration (AMD) was described for the first time in the 1840s and is currently the leading cause of blindness for patients over 65 years in Western Countries. This disease impacts the eye’s posterior segment and damages the macula,
Marie Fabre +7 more
doaj +1 more source
Multimodal imaging of dry age‐related macular degeneration [PDF]
Acta Ophthalmologica, 2012 Abstract.Purpose: The purpose of this study was to understand clinical significance of near‐infrared reflectance (NIR), blue fundus autofluorescence (FAF) and near‐infrared autofluorescence (NIA) in dry age‐related macular degeneration (AMD), by correlation with fluorescein angiography (FA) and cross‐sectional spectral domain optical coherence ...
Forte R +5 more
openaire +4 more sources
New Discoveries in Retinal Cell Degeneration and Retinal Diseases
Biomolecules, 2023 Age-related macular degeneration (AMD) has two phenotypes: dry AMD and wet AMD [...]
Puran S. Bora
doaj +1 more source
Novel approach to antiangiogenic factors in age-related macular degeneration therapy
Central European Journal of Immunology, 2022 Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss among the population above 85 worldwide. There are two main types of AMD: neovascular and dry AMD.
Katarzyna Samelska +4 more
doaj +1 more source
New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium
International Journal of Retina and Vitreous, 2020 We summarize the most important findings presented at the 2020 angiogenesis, exudation and degeneration symposium in five topic areas: (1) epidemiology of retinal vascular disease and macular degeneration; (2) dry AMD and geographic atrophy; (3 ...
Carmen A. Puliafito, Charles C. Wykoff
doaj +1 more source